Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Jonas

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
The Analyst|August 3, 2018
In vivo detection of drug-induced apoptosis in tumors using Raman spectroscopyOliver Jonas, Jeon Woong Kang, Surya P Singh, et al.
Optics Letters|June 14, 2024
Two-site microendoscopic imaging probe for simultaneous three-dimensional imaging at two anatomic locations in tissuesGuigen Liu, Sebastian W Ahn, Jeon Woong Kang, et al.
Optics Letters|August 2, 2025
Bendable graded index lens-based laser-scanning optical-resolution photoacoustic microendoscopyGuigen Liu, Shang Gao, David D Luo, et al.
IEEE Transactions on Bio-Medical Engineering|July 9, 2021
The Translational and Regulatory Development of an Implantable Microdevice for Multiple Drug Sensitivity Measurements in Cancer PatientsChristine Dominas, Sharath Bhagavatula, Elizabeth Stover, et al.
Annals of Surgery|February 7, 2022
First-in-Human Intrathoracic Implantation of Multidrug-Eluting Microdevices for In Situ Chemotherapeutic Sensitivity Testing as Proof of Concept in Nonsmall Cell Lung CancerLillian L Tsai, William W Phillips, Yin P Hung, et al.
Nature Biotechnology|July 5, 2022
A multiplex implantable microdevice assay identifies synergistic combinations of cancer immunotherapies and conventional drugsZuzana Tatarova, Dylan C Blumberg, James E Korkola, et al.
Cancer Research|March 23, 2019
Genome-Wide Interrogation of Human Cancers Identifies EGLN1 Dependency in Clear Cell Ovarian CancersColles Price, Stanley Gill, Zandra V Ho, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 10, 2020
REV1 inhibitor JH-RE-06 enhances tumor cell response to chemotherapy by triggering senescence hallmarksNimrat Chatterjee, Matthew A Whitman, Cynthia A Harris, et al.
Translational Oncology|April 26, 2022
Machine-learning aided in situ drug sensitivity screening predicts treatment outcomes in ovarian PDX tumorsMax J Cotler, Khalil B Ramadi, Xiaonan Hou, et al.
The Journal of Urology|September 30, 2024
Novel Intraprostatic Magnetic Resonance-Guided Implantation of Multidrug-Eluting Microdevice for Testing of Systemic Therapy Agents In Situ: Proof of Concept in Intermediate-Risk and High-Risk Prostate CancerBenjamin V Stone, Christine A Dominas, Sharath K Bhagavatula, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
The Analyst|August 3, 2018
In vivo detection of drug-induced apoptosis in tumors using Raman spectroscopyOliver Jonas, Jeon Woong Kang, Surya P Singh, et al.
Optics Letters|June 14, 2024
Two-site microendoscopic imaging probe for simultaneous three-dimensional imaging at two anatomic locations in tissuesGuigen Liu, Sebastian W Ahn, Jeon Woong Kang, et al.
Optics Letters|August 2, 2025
Bendable graded index lens-based laser-scanning optical-resolution photoacoustic microendoscopyGuigen Liu, Shang Gao, David D Luo, et al.
IEEE Transactions on Bio-Medical Engineering|July 9, 2021
The Translational and Regulatory Development of an Implantable Microdevice for Multiple Drug Sensitivity Measurements in Cancer PatientsChristine Dominas, Sharath Bhagavatula, Elizabeth Stover, et al.
Annals of Surgery|February 7, 2022
First-in-Human Intrathoracic Implantation of Multidrug-Eluting Microdevices for In Situ Chemotherapeutic Sensitivity Testing as Proof of Concept in Nonsmall Cell Lung CancerLillian L Tsai, William W Phillips, Yin P Hung, et al.
Nature Biotechnology|July 5, 2022
A multiplex implantable microdevice assay identifies synergistic combinations of cancer immunotherapies and conventional drugsZuzana Tatarova, Dylan C Blumberg, James E Korkola, et al.
Cancer Research|March 23, 2019
Genome-Wide Interrogation of Human Cancers Identifies EGLN1 Dependency in Clear Cell Ovarian CancersColles Price, Stanley Gill, Zandra V Ho, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 10, 2020
REV1 inhibitor JH-RE-06 enhances tumor cell response to chemotherapy by triggering senescence hallmarksNimrat Chatterjee, Matthew A Whitman, Cynthia A Harris, et al.
Translational Oncology|April 26, 2022
Machine-learning aided in situ drug sensitivity screening predicts treatment outcomes in ovarian PDX tumorsMax J Cotler, Khalil B Ramadi, Xiaonan Hou, et al.
The Journal of Urology|September 30, 2024
Novel Intraprostatic Magnetic Resonance-Guided Implantation of Multidrug-Eluting Microdevice for Testing of Systemic Therapy Agents In Situ: Proof of Concept in Intermediate-Risk and High-Risk Prostate CancerBenjamin V Stone, Christine A Dominas, Sharath K Bhagavatula, et al.
Pageof 5